She's 35 and Obsessed With Living Longer — and It Might Be Working

At 35, Kayla Barnes-Lentz has already spent more time thinking about death than most people do in a lifetime. But she's not dwelling on it — she's actively fighting it.

Barnes-Lentz has become the public face of a growing movement of women who are taking longevity science from the laboratory into their daily lives. Her regimen would make a Navy SEAL wince: cold plunges at 5 a.m., hyperbaric oxygen therapy sessions, peptide injections, a meticulously calibrated supplement stack, and a diet that reads more like a chemistry experiment than a meal plan.

The price tag? Roughly $150,000 per year. And that's before you factor in the regular blood work, genetic testing, and consultations with a team of longevity physicians.

But here's what makes Barnes-Lentz different from the typical biohacking bro: her biomarkers are actually improving. After 18 months of intensive protocol, her biological age — as measured by multiple epigenetic clocks — has dropped by an estimated four years. Her telomere length, a key marker of cellular aging, is in the 90th percentile for women her age. Her VO2 max rivals that of a competitive endurance athlete.

The longevity industry, once dominated by older men with unlimited budgets, is seeing a surge of women participants. Companies like Function Health, which offers comprehensive blood testing, report that women now make up nearly 45% of their customer base, up from 22% just two years ago.

The shift reflects a broader change in how women approach health care. For decades, the medical establishment has largely overlooked women's health concerns, from underdiagnosis of heart disease to inadequate research into menopause. The longevity movement offers something the traditional system hasn't: agency.

Not everyone is convinced. Critics argue that the science behind many longevity interventions remains thin, and that the movement's emphasis on expensive protocols creates a two-tiered system where only the wealthy can afford to extend their lives. Some physicians warn that the unregulated supplement market, in particular, poses real risks.

Barnes-Lentz acknowledges the critique but pushes back. "People spend money on things that actively shorten their lives every day," she said in a recent interview. "I'm spending money on things that might extend them. Which is the crazier investment?"

It's a question that more and more Americans — particularly women — are starting to answer for themselves. Whether the science will ultimately bear out their optimism remains to be seen. But one thing is clear: the longevity conversation is no longer just for Silicon Valley's boys' club.